Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.460
+0.060 (2.50%)
At close: Sep 28, 2026, 4:00 PM EDT
2.350
-0.110 (-4.47%)
Pre-market: Sep 29, 2026, 5:53 AM EDT
Ovid Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $4 → $5 | Buy | Reiterates | $4 → $5 | +103.25% | Sep 11, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $8 | Buy | Maintains | $8 | +225.20% | Sep 3, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $5 | Buy | Reiterates | $5 | +103.25% | Aug 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $9 | Buy | Reiterates | $9 | +265.85% | Aug 14, 2026 |
| Wedbush | Wedbush | Buy Maintains $7 | Buy | Maintains | $7 | +184.55% | Aug 14, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +103.25% | May 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.